Critical Care & Emergencies (all articles)
Podcast: Hypertension in the Hospital
25 Aug, 2020 | 03:38h | UTCAnnals On Call – Hypertension in the Hospital – Annals of Internal Medicine
Commentary on Twitter
Listen to the latest #AnnalsOnCall with @medrants, Dr Timothy Anderson, and @WrayCharles on #Hypertension in the Hospital https://t.co/OouHuYg0wt. pic.twitter.com/CbJyq7wyDq
— Annals of Int Med (@AnnalsofIM) August 24, 2020
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients
25 Aug, 2020 | 03:45h | UTC
Observational study: Revascularization practices and outcomes in patients with multivessel coronary artery disease who presented with acute myocardial infarction and cardiogenic shock
25 Aug, 2020 | 03:42h | UTCRevascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018 – JAMA Internal Medicine (free for a limited period)
Editorial: Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK (free for a limited period)
Commentaries: Multivessel PCI Associated With Higher In-Hospital Mortality Compared With Culprit-Vessel PCI, NCDR Study Finds – American College of Cardiology AND Less aggressive treatment better for heart patients who go into shock – Yale University
Related Research: PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine AND One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine
Commentary on Twitter (Thread – Click for more)
In @JAMAInternalMed is our evaluation of revascularization practices in AMI w shock
In 2017, CULPRIT-SHOCK found harm w MV-PCI in MV-CAD – in the decade preceding it, MV-PCI was an increasingly popular strategy.
?below
w/ @rwyeh @ACCinTouch https://t.co/xz0HHnvhNU pic.twitter.com/DWaVXG8vcU
— Rohan Khera (@rohan_khera) August 24, 2020
The neuroleptic malignant syndrome—a systematic case series analysis focusing on therapy regimes and outcome
25 Aug, 2020 | 03:37h | UTCCommentary: Treating Neuroleptic Malignant Syndrome: A Case Series – NEJM Journal Watch
Randomized trial: Remdesivir vs. standard care in patients with moderate COVID-19
24 Aug, 2020 | 00:53h | UTCEditorial: Efficacy of Remdesivir in COVID-19
Commentaries: Study: Remdesivir doesn’t boost outcomes in moderate pneumonia from COVID-19 – UPI AND New Remdesivir Study Shows the Trouble With Bad Science – The Wire
Commentary on Twitter
Remdesivir….good editorial, concludes we don't know who to give it to, nor for how long, nor if it improves outcomes, nor whether, if it does, it does that beyond what dexamethasone or other corticosteroids do. https://t.co/Qi1dTSPcYi
— Dr. Tom Frieden (@DrTomFrieden) August 21, 2020
COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase
24 Aug, 2020 | 00:54h | UTC
Review: The interpretation of SARS-CoV-2 diagnostic tests
24 Aug, 2020 | 00:40h | UTCThe Interpretation of SARS-CoV-2 Diagnostic Tests – Med
Recurrence or relapse of COVID‐19 in older patients: A description of three cases
24 Aug, 2020 | 00:42h | UTC
Neuroradiologic manifestations of COVID-19: What the emergency radiologist needs to know
24 Aug, 2020 | 00:32h | UTC
Dexamethasone and hydroxychloroquine: Why randomized controlled trials matter
21 Aug, 2020 | 02:37h | UTC
Evidence lags behind excitement over blood plasma as a coronavirus treatment
21 Aug, 2020 | 02:36h | UTCEvidence lags behind excitement over blood plasma as a coronavirus treatment – Nature
Histopathological findings and viral tropism in patients with severe fatal COVID-19: A post-mortem study
21 Aug, 2020 | 02:31h | UTCCommentary: Blood clots and lung injuries found in patients who have died of COVID-19 – Imperial College London
COVID-19 and cardiac arrhythmias
21 Aug, 2020 | 02:29h | UTCCOVID-19 Infection and Cardiac Arrhythmias – Trends in Cardiovascular Medicine
Management and outcomes of patients with STEMI during the COVID-19 pandemic in China
21 Aug, 2020 | 02:28h | UTC
Systematic review: Multiple vs. fewer antiplatelet agents for preventing early recurrence after ischemic stroke or transient ischemic attack
21 Aug, 2020 | 02:25h | UTC
Non-cardiac surgery in patients with coronary artery disease: Risk evaluation and periprocedural management
21 Aug, 2020 | 02:23h | UTC
Review: Effects of COVID-19 on the nervous system
20 Aug, 2020 | 09:39h | UTCEffects of COVID-19 on the nervous system – Cell
NICE Guideline: Perioperative care in adults
20 Aug, 2020 | 09:17h | UTCPerioperative care in adults – National Institute for Health and Care Excellence
Commentary on Twitter
https://t.co/1aHU3TroSp
NICE published its periop care guidelines today. Rather than being a compendium of periop medicine, it provides guidance on how the care can be improved, and should be welcomed by all periop HCPs pic.twitter.com/qlPifdUZll— Nicholas Levy (@nicholasalevy) August 19, 2020
Another randomized trial shows no benefit from ascorbic acid, corticosteroids, and thiamine in septic shock
19 Aug, 2020 | 09:28h | UTCEffect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this RCT, a combination of hydrocortisone, ascorbic acid, and thiamine (the HAT or Marik protocol) did not statistically significantly reduce SOFA score or mortality within 72 hours of enrollment among patients with septic shock https://t.co/cuB6X4fJhi
— JAMA (@JAMA_current) August 18, 2020
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
19 Aug, 2020 | 09:23h | UTC
SARS-CoV-2 transmission in a community setting before and after the use of face shields
18 Aug, 2020 | 07:51h | UTC
Study suggests low risk of post-discharge venous thromboembolism following hospital admission with COVID-19
16 Aug, 2020 | 22:24h | UTCPost-discharge venous thromboembolism following hospital admission with COVID-19 – Blood
Commentary: Post-Hospital Venous Thromboembolism in Patients With COVID-19 – American College of Cardiology
Clinical update: Influenza in the COVID-19 era
16 Aug, 2020 | 22:31h | UTCInfluenza in the COVID-19 Era – JAMA
Commentary on Twitter
Despite the rapid pace of progress in the areas of #SARSCoV2 diagnostics, treatment, and vaccine development, the population remains vulnerable to concurrent influenza and #COVID19 epidemics https://t.co/414veJwuYj
— JAMA (@JAMA_current) August 14, 2020
Cohort study: ECMO for severe acute respiratory distress syndrome associated with COVID-19
16 Aug, 2020 | 22:28h | UTCInvited Commentary: ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? – The Lancet Respiratory Medicine
Commentary on Twitter
Our approaches and treatments for severe #COVID19 keep getting better. Use of blood thinners, dexamethasone, when to use mechanical ventilation, etc. We're also getting smarter about the use of ECMO@LancetRespirMed https://t.co/LXfZnVaEJ8@JAMASurgery https://t.co/Osmjne9btb pic.twitter.com/Pq1u6TMNV8
— Eric Topol (@EricTopol) August 14, 2020
Diagnosing COVID‐19 in the ED: A scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases
16 Aug, 2020 | 22:23h | UTC